TNFR2: The new Treg switch?
Three recent publications identified the TNF/TNR2 pathway as a new target to reduce graft-versus-host-disease through regulatory T cells activation or to potentially switch on a strong anti-leukemic effect through regulatory T cells blockade in allogeneic hematopoietic stem cell transplantation. Thi...
Main Authors: | Cohen, JL, Wood, KJ |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
Taylor and Francis
2017
|
פריטים דומים
-
TNFR2: The new Treg switch?
מאת: José L. Cohen, et al.
יצא לאור: (2018-01-01) -
TNFR1 and TNFR2 Expression and Induction on Human Treg Cells from Type 1 Diabetic Subjects
מאת: Melanie Heinrich, et al.
יצא לאור: (2015-03-01) -
TNFR2 blockade promotes antitumoral immune response in PDAC by targeting activated Treg and reducing T cell exhaustion
מאת: Eliane Piaggio, et al.
יצא לאור: (2024-11-01) -
A TNFR2-Agonist Facilitates High Purity Expansion of Human Low Purity Treg Cells.
מאת: Xuehui He, et al.
יצא לאור: (2016-01-01) -
Fn14 and TNFR2 as regulators of cytotoxic TNFR1 signaling
מאת: Daniela Siegmund, et al.
יצא לאור: (2023-11-01)